Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.

PubWeight™: 2.98‹?› | Rank: Top 1%

🔗 View Article (PMID 8901854)

Published in J Natl Cancer Inst on November 06, 1996

Authors

D Albanes1, O P Heinonen, P R Taylor, J Virtamo, B K Edwards, M Rautalahti, A M Hartman, J Palmgren, L S Freedman, J Haapakoski, M J Barrett, P Pietinen, N Malila, E Tala, K Liippo, E R Salomaa, J A Tangrea, L Teppo, F B Askin, E Taskinen, Y Erozan, P Greenwald, J K Huttunen

Author Affiliations

1: Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD 20892-7326, USA.

Articles citing this

Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev (2008) 5.74

Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med (2007) 2.55

Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43

Plants antioxidants: From laboratory to clinic. J Nephropathol (2013) 2.39

Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 2.25

Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med (2011) 1.93

Dual Association of beta-carotene with risk of tobacco-related cancers in a cohort of French women. J Natl Cancer Inst (2005) 1.79

Tocotrienols: Vitamin E beyond tocopherols. Life Sci (2006) 1.61

Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis (2009) 1.59

Foodstuffs for preventing cancer: the preclinical and clinical development of berries. Cancer Prev Res (Phila) (2009) 1.41

Potential role of carotenoids as antioxidants in human health and disease. Nutrients (2014) 1.29

Beta-Carotene and lung cancer promotion in heavy smokers--a plausible relationship? J Natl Cancer Inst (1996) 1.22

Cancer chemoprevention: a rapidly evolving field. Br J Cancer (2013) 1.20

A gamma-tocopherol-rich mixture of tocopherols inhibits chemically induced lung tumorigenesis in A/J mice and xenograft tumor growth. Carcinogenesis (2010) 1.16

Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prev Res (Phila) (2011) 1.14

How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality. Dermatoendocrinol (2009) 1.13

Cancer prevention research - then and now. Nat Rev Cancer (2009) 1.12

Adipokine genes and prostate cancer risk. Int J Cancer (2009) 1.10

The neglected significance of "antioxidative stress". Oxid Med Cell Longev (2012) 1.06

Lifestyle and diet in people using dietary supplements: a German cohort study. Eur J Nutr (2007) 1.03

Marine carotenoids: biological functions and commercial applications. Mar Drugs (2011) 1.02

Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br J Cancer (2003) 1.01

Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev Res (Phila) (2012) 1.01

Does vitamin E prevent or promote cancer? Cancer Prev Res (Phila) (2012) 1.01

Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS). Dose Response (2014) 1.00

Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications. Br J Clin Pharmacol (1998) 0.99

Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids. Clin Dev Immunol (2008) 0.98

Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail. Cancer Prev Res (Phila) (2009) 0.98

Effects of beta-carotene supplementation on molecular markers of lung carcinogenesis in male smokers. Cancer Prev Res (Phila) (2010) 0.98

Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog Retin Eye Res (2015) 0.98

Toward a new philosophy of preventive nutrition: from a reductionist to a holistic paradigm to improve nutritional recommendations. Adv Nutr (2014) 0.96

An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol (2010) 0.95

Antioxidant therapeutics: Pandora's box. Free Radic Biol Med (2013) 0.93

Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary. Eur J Nutr (2012) 0.93

LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. Epigenetics (2013) 0.93

Plant science and human nutrition: challenges in assessing health-promoting properties of phytochemicals. Plant Cell (2011) 0.93

Intraindividual variability in serum micronutrients: effects on reliability of estimated parameters. Epidemiology (2009) 0.92

Antioxidant induces DNA damage, cell death and mutagenicity in human lung and skin normal cells. Sci Rep (2013) 0.91

Longitudinal biological exposure to carotenoids is associated with breast cancer-free survival in the Women's Healthy Eating and Living Study. Cancer Epidemiol Biomarkers Prev (2009) 0.91

Iron and thiols as two major players in carcinogenesis: friends or foes? Front Pharmacol (2014) 0.91

Skin photoaging and the role of antioxidants in its prevention. ISRN Dermatol (2013) 0.90

Perspective: A Critical Look at the Ancillary Age-Related Eye Disease Study 2: Nutrition and Cognitive Function Results in Older Individuals with Age-Related Macular Degeneration. Adv Nutr (2016) 0.89

Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer. J Gen Intern Med (2006) 0.88

Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget (2016) 0.86

Retinoic acid regulates cell cycle genes and accelerates normal mouse liver regeneration. Biochem Pharmacol (2014) 0.86

Metabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (2013) 0.86

Nutrient intake and nutrient patterns and risk of lung cancer among heavy smokers: results from the COSMOS screening study with annual low-dose CT. Eur J Epidemiol (2013) 0.85

Helicobacter pylori seropositivity and risk of lung cancer. PLoS One (2012) 0.85

Treatment- and disease-related complications of prostate cancer. Rev Urol (2006) 0.84

LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk. Epigenetics (2015) 0.83

Vitamin d: are we ready to supplement for breast cancer prevention and treatment? ISRN Oncol (2013) 0.83

Non-specific protein modifications by a phytochemical induce heat shock response for self-defense. PLoS One (2013) 0.82

Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Int J Cancer (2013) 0.82

Antioxidant-induced stress. Int J Mol Sci (2012) 0.82

In Vitro and In Vivo Studies of Non-Platinum-Based Halogenated Compounds as Potent Antitumor Agents for Natural Targeted Chemotherapy of Cancers. EBioMedicine (2015) 0.82

The effect of carrot juice, β-carotene supplementation on lymphocyte DNA damage, erythrocyte antioxidant enzymes and plasma lipid profiles in Korean smoker. Nutr Res Pract (2011) 0.81

The chemotactic activity of beta-carotene in endothelial cell progenitors and human umbilical vein endothelial cells: A microarray analysis. Exp Clin Cardiol (2006) 0.80

The antioxidants dilemma: are they potentially immunosuppressants and carcinogens? Front Physiol (2014) 0.80

Longitudinal and secular trends in dietary supplement use: Nurses' Health Study and Health Professionals Follow-Up Study, 1986-2006. J Acad Nutr Diet (2013) 0.80

Oxidant stress promotes disease by activating CaMKII. J Mol Cell Cardiol (2015) 0.80

Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis. PLoS One (2011) 0.80

Supplementation with alpha-tocopherol or beta-carotene reduces serum concentrations of vascular endothelial growth factor-D, but Not -A or -C, in male smokers. J Nutr (2011) 0.80

Combination of physical activity, nutrition, or other metabolic factors and vaccine response. Front Biosci (2007) 0.80

Combined α-tocopherol and ascorbic acid protects against smoke-induced lung squamous metaplasia in ferrets. Lung Cancer (2011) 0.80

Genotoxic effects of carotenoid breakdown products in human retinal pigment epithelial cells. Curr Eye Res (2009) 0.80

Beta-carotene affects gene expression in lungs of male and female Bcmo1 (-/-) mice in opposite directions. Cell Mol Life Sci (2010) 0.79

Cancer prevention and control: alarming challenges in China. Natl Sci Rev (2015) 0.79

Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention. Cancers (Basel) (2014) 0.79

Angiogenesis in Balb/c mice under beta-carotene supplementation in diet. Genes Nutr (2009) 0.78

Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? Cancer Metastasis Rev (2013) 0.78

Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. J Clin Invest (2016) 0.78

Absorption, metabolism, and functions of β-cryptoxanthin. Nutr Rev (2016) 0.78

Nutriceuticals in health and disease prevention. Indian J Clin Biochem (2004) 0.78

Chemoprevention of lung cancer: prospects and disappointments in human clinical trials. Cancers (Basel) (2013) 0.78

Sources of vitamin A in the diets of pre-school children in the Avon Longitudinal Study of Parents and Children (ALSPAC). Nutrients (2013) 0.78

Effects of particulate matter and antioxidant dietary intake on blood pressure. Am J Public Health (2014) 0.77

Randomised beta-carotene supplementation and incidence of cancer and cardiovascular disease in women: is the association modified by baseline plasma level? Br J Cancer (2002) 0.77

Nutritional Solutions to Reduce Risks of Negative Health Impacts of Air Pollution. Nutrients (2015) 0.77

What is the association of lipid levels and incident stroke? Int J Cardiol (2016) 0.77

Carotenoids and total phenolic contents in plant foods commonly consumed in Korea. Nutr Res Pract (2012) 0.77

Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma. Curr Cancer Ther Rev (2012) 0.77

General supplement use, subsequent use and cancer risk in the UK Women's Cohort Study. Eur J Clin Nutr (2014) 0.76

Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice. BMC Gastroenterol (2014) 0.76

Tocopherols in cancer: An update. Mol Nutr Food Res (2016) 0.76

Animal models in carotenoids research and lung cancer prevention. Transl Oncol (2011) 0.76

Lung cancer. 1: prevention of lung cancer. Thorax (2002) 0.76

A comparison of retinyl palmitate and red palm oil β-carotene as strategies to address Vitamin A deficiency. Nutrients (2013) 0.76

Flavonoid intakes in the Baltimore Longitudinal Study of Aging. J Food Compost Anal (2011) 0.76

Blood concentrations of carotenoids and retinol and lung cancer risk: an update of the WCRF-AICR systematic review of published prospective studies. Cancer Med (2016) 0.76

Solid-phase extraction and GC-MS analysis of potentially genotoxic cleavage products of β-carotene in primary cell cultures. Anal Bioanal Chem (2011) 0.76

Retinoic Acid-mediated Nuclear Receptor Activation and Hepatocyte Proliferation. J Exp Clin Med (2009) 0.75

Validation and application of sub-2 μm core-shell UHPLC-UV-ESI-Orbitrap MS for identification and quantification of β-carotene and selected cleavage products with preceding solid-phase extraction. Anal Bioanal Chem (2014) 0.75

Healthy Dietary Patterns and Oxidative Stress as Measured by Fluorescent Oxidation Products in Nurses' Health Study. Nutrients (2016) 0.75

Tomato as a Source of Carotenoids and Polyphenols Targeted to Cancer Prevention. Cancers (Basel) (2016) 0.75

Methodological problems with population cancer studies: The forgotten confounding factors. Surg Neurol Int (2015) 0.75

Vitamins, Are They Safe? Adv Pharm Bull (2016) 0.75

Biosynthesis, characterization, and efficacy in retinal degenerative diseases of lens epithelium-derived growth factor fragment (LEDGF1-326), a novel therapeutic protein. J Biol Chem (2013) 0.75

The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration. Adv Nutr (2017) 0.75

JNCI and cancer prevention. J Natl Cancer Inst (2015) 0.75

Articles by these authors

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med (1987) 13.50

A data-based approach to diet questionnaire design and testing. Am J Epidemiol (1986) 12.68

Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17

Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med (2001) 10.56

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst (1993) 8.30

Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol (1997) 7.62

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59

Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73

Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med (1992) 5.65

The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev (1999) 5.49

A reduced dietary questionnaire: development and validation. Epidemiology (1990) 5.41

Socioeconomic factors and cancer incidence among blacks and whites. J Natl Cancer Inst (1991) 5.39

Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34

Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet (1983) 5.31

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA (2001) 5.28

Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation (1992) 4.96

The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer (2000) 4.89

Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst (1998) 4.72

Workplace smoking policies in the United States: results from a national survey of more than 100,000 workers. Tob Control (1997) 4.52

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41

Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet (2001) 4.39

Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst (2001) 4.26

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet (1997) 4.19

Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc (1992) 3.91

On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82

Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol (2000) 3.78

Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J (1979) 3.75

Detection and identification of mycobacteria by amplification of a segment of the gene coding for the 32-kilodalton protein. J Clin Microbiol (1992) 3.62

Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst (1996) 3.52

Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51

Lung cancer and exposure to tobacco smoke in the household. N Engl J Med (1990) 3.23

Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 3.19

Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet (1990) 3.03

Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study. Lancet (1995) 3.03

Nutrient sources in the American diet: quantitative data from the NHANES II survey. II. Macronutrients and fats. Am J Epidemiol (1985) 3.02

Consistent dietary patterns identified from childhood to adulthood: the cardiovascular risk in Young Finns Study. Br J Nutr (2005) 3.00

Campylobacter fetus infection in human subjects: association with raw milk. Am J Med (1979) 2.99

Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer (1998) 2.94

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA (1988) 2.89

Socio-economic conditions in childhood and mortality and morbidity caused by coronary heart disease in adulthood in rural Finland. Soc Sci Med (1985) 2.87

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet (1994) 2.83

Sinistrality--a side-effect of prenatal sonography: a comparative study of young men. Epidemiology (2001) 2.80

Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis. Cancer (1979) 2.76

Estimation of multivariate frailty models using penalized partial likelihood. Biometrics (2000) 2.70

Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67

Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62

Body iron stores and the risk of cancer. N Engl J Med (1988) 2.61

Estimated effect of breast self-examination and routine physician examinations on breast-cancer mortality. N Engl J Med (1978) 2.60

Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst (1993) 2.59

Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol (2000) 2.59

Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol (1988) 2.53

Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer (1998) 2.48

Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer (2004) 2.46

State-specific trends in smoke-free workplace policy coverage: the current population survey tobacco use supplement, 1993 to 1999. J Occup Environ Med (2001) 2.45

Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry (1999) 2.44

Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst (2001) 2.43

Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40

Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer (1998) 2.39

Revision of dietary analysis software for the Health Habits and History Questionnaire. Am J Epidemiol (1994) 2.37

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet (1986) 2.34

Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33

Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst (2000) 2.32

Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32

Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32

Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut (2005) 2.31

Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29

K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res (1996) 2.29

Adult stature and risk of cancer. Cancer Res (1988) 2.26

Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (1995) 2.25

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control (2000) 2.24